Arylomycin B1 is a natural product belonging to the class of compounds known as arylomycins, which are derived from the bacterium *Streptomyces* species. This compound exhibits notable antibacterial properties, particularly against Gram-positive bacteria, making it of interest in the field of antibiotic research. Arylomycin B1 functions by inhibiting bacterial protein synthesis, specifically targeting the bacterial signal recognition particle (SRP) pathway, which is crucial for the proper localization of membrane proteins. Its unique structure features a bicyclic core that contributes to its biological activity. Additionally, Arylomycin B1 has shown potential in overcoming antibiotic resistance, a significant challenge in contemporary medicine. The compound's pharmacological profile suggests it may serve as a lead compound for the development of new antibiotics. However, further studies are necessary to fully understand its mechanism of action, efficacy, and safety profile in clinical settings. Overall, Arylomycin B1 represents a promising candidate in the ongoing search for novel antimicrobial agents.

Arylomycin B1

459844-24-7: Arylomycin B1 is a natural product belonging to the class of compounds known as arylomycins, which are derived from the bacterium *Streptomyces* species. This compound exhibits notable antibacterial properties, particularly against Gram-positive bacteria, making it of interest in the field of antibiotic research. Arylomycin B1 functions by inhibiting bacterial protein synthesis, specifically targeting the bacterial signal recognition particle (SRP) pathway, which is crucial for the proper localization of membrane proteins. Its unique structure features a bicyclic core that contributes to its biological activity. Additionally, Arylomycin B1 has shown potential in overcoming antibiotic resistance, a significant challenge in contemporary medicine. The compound's pharmacological profile suggests it may serve as a lead compound for the development of new antibiotics. However, further studies are necessary to fully understand its mechanism of action, efficacy, and safety profile in clinical settings. Overall, Arylomycin B1 represents a promising candidate in the ongoing search for novel antimicrobial agents.

<p>Arylomycin B1 is a lipid hexapeptide antibiotic (antibiotic) effective against Gram-positive bacteria.</p>

CAS 459844-24-7

Arylomycin B1

Arylomycin B1

Ref: TM-TN9095